Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (72)

2026

  1. Bilateral pheochromocytoma: differences in clinical and surgical outcomes with unilateral pheochromocytomas

    Endocrine, Vol. 91, Núm. 1

  2. CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry

    Hematological Oncology, Vol. 44, Núm. 1

  3. Comparison of routine clinical profiles of patients with imported P. falciparum malaria and co-infection with Plasmodium ovale wallikeri or Plasmodium ovale curtisi

    Acta Tropica, Vol. 274

  4. Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study

    European Journal of Haematology, Vol. 116, Núm. 4, pp. 450-457

  5. Expanded Hemodialysis Using a Medium Cut-Off Dialyzer for Severe Valproic Acid Poisoning: A Case Report with Real-Time Therapeutic Drug Monitoring

    Journal of Clinical Medicine, Vol. 15, Núm. 6

  6. Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratories

    Leukemia Research, Vol. 160

  7. Is there a window of opportunity in the treatment of giant cell arteritis with tocilizumab? Multicenter study of 471 patients

    Seminars in Arthritis and Rheumatism, Vol. 78

  8. Multidisciplinary management of acute osteoporotic vertebral fracture: results of a national Delphi consensus

    Archives of osteoporosis, Vol. 21, Núm. 1, pp. 38

  9. One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib

    Annals of Hematology, Vol. 105, Núm. 2

  10. Oxygen saturation and mortality for acute pulmonary embolism: multinational retrospective cohort study

    eClinicalMedicine, Vol. 94

  11. Prevalence and prognostic impact of subclinical venous congestion in patients hospitalized for acute heart failure

    European Heart Journal: Acute Cardiovascular Care, Vol. 14, Núm. 12, pp. 749-753

  12. Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study

    Journal of Clinical Oncology

  13. Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study

    American Journal of Hematology

  14. Transthyretin-related cardiac amyloidosis. A review of current treatments and future prospects

    REC: CardioClinics

2025

  1. ASO Visual Abstract: Outcomes for Patients with Obesity Undergoing Adrenalectomy for Pheochromocytoma-An International Multicenter Analysis

    Annals of surgical oncology, Vol. 32, Núm. 4, pp. 2376-2378

  2. Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure

    European Heart Journal, Vol. 46, Núm. 48, pp. 5222-5233

  3. Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience

    Transplantation and Cellular Therapy, Vol. 31, Núm. 5, pp. 299.e1-299.e14

  4. Bicaval TricValve Implantation in Patients With Severe Tricuspid Regurgitation: 1-Year Outcomes From the TricBicaval Registry

    JACC: Cardiovascular Interventions, Vol. 18, Núm. 15, pp. 1913-1924

  5. Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group study

    BMC infectious diseases, Vol. 25, Núm. 1, pp. 944

  6. Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study

    Cancers, Vol. 17, Núm. 5